enhanced at 5-7 days after birth, and decreased thereafter. In BPD, the expression of GATA-6 in alveolar epithelial cells was low. These results were confirmed and extended using an established baboon model of prematurity. The in vitro experiments revealed that TGF-␤ 1 induces GATA-6 and thyroid transcription factor 1 expression in lung epithelial cells. Conclusions: Our results suggest that the expression of GATA-6 at the early stages of the preterm lung may be related to impaired postnatal alveolar development.
components are believed to be pre-and postnatal inflammation, as well as oxygen toxicity, which can further damage the lung [2] . The development of BPD has been also been linked to alterations in critical signaling pathways, such as in the TGF-␤ superfamily [5] .
Several factors are involved in the normal pulmonary development and pathophysiology of neonatal lung disease. Transcription factors are essential regulators of gene expression, and their abnormalities have been associated with disease in several organs. GATA transcription factors are zinc finger proteins that recognize a consensus DNA sequence (A/T) GATA (A/G), known as GATA-motif, which is an essential cis -acting element in the promoters and enhancers of a variety of genes [6] . GATA-4, GATA-5, and GATA-6 are expressed in the foregut or cardiac regions of the developing embryo, suggesting a potential role in organogenesis of the heart and lung [7] [8] [9] . These GATA proteins are also expressed in the developing mouse lung [8] [9] [10] [11] .
Out of the three GATA factors implicated in lung development, GATA-6 has been most extensively studied in the developing airway epithelium [9] . Conditional loss of function mouse models revealed that GATA-6 is required for lung maturation at the saccular stage [12] . A generalized delay in lung maturation and decreased surfactant protein B levels were observed in this model, and postnatal survival was decreased in comparison with wild-type littermates [12] . The expression of GATA-6 is normally downregulated at term in murine lung, and this seems to be essential for proper lung maturation, whereas overexpressing GATA-6 in the postnatal respiratory epithelial type II cells inhibits alveolarization and perturbs lung function [13] . Subsequent studies on murine lung have shown that GATA-6 enhances transcription of surfactant A and C genes [14, 15] . In addition, it interacts with thyroid transcription factor 1 (TTF-1), also involved in the regulation of surfactant gene expression [14, 16] . TTF-1 on the other hand regulates thyreoglobulin, the macromolecular precursor of thyroid hormones, which in turn may be involved in orchestrating the complex steps involved in lung morphogenesis [17] .
Collectively, the published data on experimental models suggest that GATA-6, together with its cofactors and downstream target genes, has a central role in normal mammalian lung development and function. We postulated that abnormalities in the expression of GATA-6 might also be associated with abnormal lung development in primates, and assessed its expression during fetal and neonatal human lung development and disease. As the overexpression of TGF-␤ in the neonatal mouse lung results in histological changes similar to BPD [18] , and TGF-␤ is known to contribute to postnatal fibrosis after alveolar injury [5, 19] , the relationship of GATA-6 and TGF-␤ in pulmonary epithelial cells was studied in vitro.
Materials and Methods

Human Lung Tissue
The human lung biopsies were obtained from autopsy material (Children's Hospital, Helsinki University Central Hospital) of fetal or preterm/term infants, taken within 3 days post-mortem ( table 1 ) . The permission to use the material in scientific purposes was obtained from the National Authority for Medicolegal Affairs. The samples were divided into three different groups according to the patient's age and specific diagnosis: (1) fetus; (2) newborn at term; (3) preterm with RDS at 1-2 days after birth; (4) preterm with RDS at 3-7 days after birth; (5) preterm with RDS at 7 days or more after birth, and (6) preterm with BPD. BPD was defined using the published criteria [20] . Antenatal betamethasone treatment was not part of the clinical routine at the time of sample collection, and none of the patients received prophylactic glucocorticoid treatment during the early postnatal period.
Premature Primate Model
All animal studies were performed at the Southwest Foundation for Biomedical Research Primate Center (San Antonio, Tex., USA) and protocols and procedures were approved by the Institutional Animal Care and Use Committee. Fetal baboons (gestational controls, GCs) of varying gestational ages (125, n = 6; 140, n = 5; 160, n = 4; 175, n = 4, 8 2 days) were delivered by hysterotomy and euthanized at birth before onset of breathing. The lung samples from term animals (185 + 2 days, n = 6) were collected following term natural delivery. The preterm animals (125 + 2 days, n = 4; 125 + 6 days, n = 4; 125 + 14 days, n = 6; 125 + 21 days, n = 5), also delivered by hysterotomy, were resuscitated, placed on ventilatory support with pro re nata (PRN) O 2 , and cared for as previously described [21, 22] . 125 and 140 days of baboon gestation correspond to 27 and 32 human gestational weeks, respectively. The 125 + 14 or 21 days PRN O 2 animals develop lung histopathological lesions similar to human BPD [21] . All samples were collected during years 1996-2004, and at necropsy they were immediately fixed with 4% paraformaldehyde.
Immunohistochemistry
Immunoperoxidase staining of human and baboon samples for GATA-6 and human samples for TTF-1 followed the protocol previously described [23] . Rabbit polyclonal GATA-6 (Santa Cruz Biotechnology; dilution 1: 200) and mouse monoclonal anti-TTF-1 (8G7G3/1; Abcam; dilution 1: 100), primary antibodies were used for the staining. The primary antibodies were incubated overnight at +4 ° C. In control experiments, nonimmune serum (Sigma; I8140-10 mg) replaced the primary antibody, or the sections were incubated with secondary antibody without primary antibody. For each sample, approximately 10 areas of stained sections were evaluated by 2 observers (R.V. and R.K.). For human samples, the proportion of positivity to each nuclear antigen was evaluated as follows: low intensity (+) for 0-20% positive nuclei or 1-80% positive cells with weak immunoreactivity, intermediate intensity (++) for 20-100% positive nuclei with at least moderate immunoreactivity, and high intensity (+++) for 80-100% positive nuclei. For baboon samples, quantitation of staining was carried out using a semiquantitative scoring system (0 = negative, 1 = mild, 2 = moderate, and 3 = intense staining). Preprepared tables were used listing the following structures and cell types: alveolar epithelium and bronchiolar/bronchial epithelium, arterial and capillary endothelium, and matrix cells (fibroblasts, smooth muscle cells).
Cell Lines and TGF-␤ Exposure in vitro
Human A549 adenocarcinoma (American Type Culture Collection, Manassas, Va., USA) cells derived from alveolar type II cells and BEAS-2B cells (National Cancer Institute, Laboratory of Human Carcinogenesis, Dr. C. Harris, Bethesda, Md., USA), which are SV40-transformed human bronchial epithelial cells, were used for the in vitro experiments. The cell lines cells were grown in DMEM or bronchial epithelial cell growth medium supplemented with 10% FBS, 1% L -glutamine and 1% penicillinstreptomycin. The effect of TGF-␤ on GATA-6 and TTF-1 transcription factors was evaluated in both cell lines by exposing the cells to 2 or 10 ng/ml of recombinant human TGF-␤ 1 (R&D Systems), and the experiments were repeated three times. The cells were seeded on 6-well plates and allowed to attach and expand to subconfluency for 48 h. The cells were serum starved for 24 h, whereafter TGF-␤ in DMEM supplemented with 1% FBS was added to the cells for 6 h. After the exposure, the cells were harvested in RNA lysis buffer for RNA isolation.
RNA Extraction and RT-PCR
Total RNA was extracted from the A549 and BEAS-2B cells, and contaminating genomic DANN eliminated using RNeasy Mini Kit (Qiagen: 250, Cat. No. 74106). All experiments were repeated at least three times. First strand cDNA synthesis was per- formed from 1 g of total RNA using SYBR Green RT-PCR reagents and random hexamers (Applied Biosystems, Foster City, Calif., USA). The primers (Oligomer) were designed using the ABI Primer Express software (Applied Biosystems) applied to cDNA sequences derived from the UCSC Genome Bioinformatics Site web site (http://genome.ucsc.edu/) and were as follows: GATA-6 sense: 5 -ATG ACT CCA ACT TCC ACC TCT, GATA-6 antisense 5 -CAG CCT CCA GAG ATG TGT AC G, TTF-1 sense 5 -CCT GGC GCT TCA TTT TGT AG, TTF-1 antisense 5 -ACC AGG ACA CCA TGA GGA AC, GAPDH sense 5 -TCA TTT CCT GGT ATG ACA ACG, GAPDH antisense 5 -TTA CTC CTT GGA GGC CAT GT. Analysis of GATA-4, GATA-6, TTF-1 and GAPDH expression was performed using the PTC-200 Peltier Thermal Cycler (MJ Research). Densitometric analysis on the bands was performed using Media Cybernetics Image J software for Macintosh.
Results
GATA-6 Expression Is High in Human Fetal Lung Epithelium and Diminishes towards Term
GATA-6 expression could be detected in early human fetal lung, and it localized to the developing airway epithelium ( fig. 1 ). The early fetal pulmonary tissue (pseudoglandular phase of development, ! 18 weeks) lacks a mature alveolar epithelium and the alveolar wall is lined by a non-differentiated epithelial cell layer that can be identified by a typical morphology. Intensive GATA-6 immunoreactivity was detectable in these early terminal airspaces ( fig. 1 a) . In addition to the saccular epithelial cells, some positivity was observed within the developing bronchial epithelial cells (not shown). The parenchymal tissue in the developing lung in turn, consists of a relatively thick, loose layer of fibroblasts and connective tissue. No GATA-6 immunoreactivity was observed in the parenchymal fibroblasts. With advancing gestational age, expression confined to the epithelial cells, presumably type II cells. The staining intensity at this time was, however, clearly weaker than in early fetal period ( fig. 1 c; table 1 ).
TTF-1 Expression Follows Epithelial GATA-6 Expression in the Developing Human Lung
Next, we wanted to analyze the expression of a pulmonary GATA-6 cofactor and putative target gene TTF-1 during lung development. TTF-1 expression is generally confined to the saccular/alveolar epithelial cells in the developing lung. TTF-1 was expressed in the human fetal lung very similarly to GATA-6 ( table 1 ; fig. 1 b, d) , confining to the developing alveolar epithelial cells. Similarly, the intensity of TTF-1 was higher in the earlier phases of development. The lung parenchymal tissue was always TTF-1 negative. The expression of TTF-1 in bronchial epithelial cells varied between individual samples, so that weak to intensive staining was observed (not shown). 
Pulmonary Epithelial GATA-6 Expression Is First Enhanced in RDS, but Then Decreases with Prolonged Disease and the Development of BPD in Premature Lung
To assess the relationship of GATA-6 expression with the duration and/or severity of neonatal lung disease, three groups of neonates with RDS of varying length of the disease and 2 neonates with BPD were analyzed. GATA-6 expression was studied in three distinct phases of RDS: 1-2 days, 3-7 days or over 7 days after birth. In addition, six samples from patients with BPD were included.
The staining for GATA-6 was strongest in the airway epithelium of the group with intermediate-length table 1 ). In all groups, GATA-6 expression was stronger in the alveolar epithelium than in the bronchial epithelium. In 2/4 1-to 2-day RDS samples ( table 1 ; patients 8 and 9), the alveolar epithelium showed weak positive GATA-6 immunoreactivity, and the expression intensified in the 3-7 days group ( table 1 ; patients 12-15). Of interest, some parenchymal cells in the 3-to 7-day RDS group were GATA-6 positive in specimens, in which epithelial positivity was also observed ( fig. 2 c) . In the patient group with prolonged RDS ( 1 7 days), GATA-6 levels were lower than in the two other RDS groups, and the positive cells were observed only in the peribronchial and parenchymal fibroblasts ( fig. 2 e) . If RDS leads to BPD, the morphology of the lung parenchyma is altered so that the reactive alveolar epithelium in RDS is replaced by -or difficult to distinguish from -an increased population of parenchymal fibroblasts. In the neonatal lungs with typical BPD, the epithelial GATA-6 staining was almost negligible with only some positivity in the peribronchial fibroblasts ( fig. 2 g) .
All in all, GATA-6 expression is enhanced during the first week of RDS and decreases along with the duration of the disease. GATA-6 localizes to the reactive epithelium and the parenchymal fibroblasts beneath it.
Expression of TTF-1 Resembles That of GATA-6 in the Human RDS Lung
Next, we wanted to analyze the expression of TTF-1 during lung development and disease. Similarly to GATA-6, epithelial TTF-1 expression was high in early fetal lung and decreased towards term ( fig. 1 b, d) . The pulmonary TTF-1 expression in neonatal lung disease ( fig. 2 ; table 1 ) coincided partially with that of GATA-6, with the exception that alveolar epithelial cells showed positivity for TTF-1 already in 1-to 2-day RDS ( fig. 2 b) . TTF-1 expression was strongest in intermediate/long disease ( fig. 2 d,  f) and negligible in BPD, only very weak immunoreactivity being observed in the alveolar epithelium ( fig. 2 h) . In contrast to GATA-6 staining, TTF-1 was not detected in the parenchyma, but was solely confined to type II epithelial cells; this finding is in accordance with earlier reports on the specificity of TTF-1 as a marker of type II cells [24, 25] .
GATA-6 Expression in Fetal and Preterm Baboon Lung
Studies using human tissues are challenging due to difficulties in obtaining samples from large numbers of individuals and especially from healthy, age-matched controls. We therefore confirmed and extended our results of GATA-6 in human material in an established baboon model of prematurity. During the last trimester of baboon gestation, there was a trend toward decreased expression of GATA-6 protein in bronchiolar epithelium. In addition, the cells that had an appearance of interstitial fibroblasts, and arterial smooth muscle and endothelial cells had less GATA-6 immunoreactivity ( table 2 ). There was a moderate, but unchanged, GATA-6 positivity in alveolar epithelium during fetal baboon ontogenesis ( table 2 ). GATA-6 expression was somewhat increased in baboon RDS (125 + 2 or 6 days PRN O 2 ; table 2 ; fig. 3 b) compared with age-matched GCs ( fig. 3 a) . Specifically, there was a stronger GATA-6 expression in bronchiolar epithelium of 125 + 2 and/or 6 days PRN O 2 baboons compared with age-matched GCs (125 days' gestation; table 2 ). Moreover, the high GATA-6 expression in baboon RDS appeared to decrease in evolving BPD (125 + 14 days PRN O 2 ), especially in saccular/alveolar and bronchiolar epithelium ( table 2 ) . When compared with the age-matched fetal controls (140 days' gestation GCs; fig. 3 fig. 3 d) . The nonimmune serum and/or secondary antibody without primary antibody controls was negative for each section (not shown).
TGF-␤ Upregulates GATA-6 and TTF-1 mRNA Expression in Pulmonary Epithelial Cell Lines
Several lines of evidence implicate TGF-␤ as a central regulator of tissue repair and profibrotic signaling, especially in the lung. Possible regulation of GATA-6 by TGF-␤ was investigated in two established pulmonary epithelial cell lines, A549 and BEAS-2B. Neither cell line expressed detectable levels of GATA-6 before the treatment with TGF-␤ ( fig. 4 for A549 ; data not shown for BEAS-2B). Recombinant TGF-␤ 1 in concentrations of 2 and 10 ng/ml upregulated GATA-6 mRNA expression in the two cell lines ( fig. 4 for A549 ; data not shown for BEAS-2B), and a more pronounced effect was detectable at the 2 ng/ml concentration, which is the biologically effective dose used widely in TGF-␤ research. To test whether GATA-6 would act specifically as a mediator of the TGF-␤ effects, RT-PCR for GATA-4, a closely related gene to GATA-6 also expressed in the lung, was performed as a control. In contrast to GATA-6 mRNA expression, there was a small decrease in GATA-4 levels (40% in the 2 ng/ml group and and 70% in the 10 ng/ml group) in treated versus untreated cells in A549 cells ( fig. 4 ) , and in the BEAS-2B cells no detectable levels of GATA-4 were found in any group, stimulated or nonstimulated (not shown). The effect of TGF-␤ on the TTF-1 mRNA by RT-PCR was investigated next, and, similarly to GATA-6, TTF-1 was induced slightly by TGF-␤ ( fig. 4 ; data not shown for BEAS-2B cells). A basal expression of TTF-1 level was also detectable in the non-stimulated cells. GAPDH levels remained unchanged in the stimulated versus nonstimulated cells ( fig. 4 for A549 ; data not shown for BEAS-2B). 
Discussion
Acute RDS and BPD remain central problems in the care of preterm infants. Several advances have been encountered in the understanding of these conditions during the last decades, albeit there are still open questions in the underlying molecular mechanisms. We herein utilized prenatal and neonatal human and baboon lung samples, and performed cell culture studies to elucidate the role of TGF-␤ and transcription factor GATA-6 as well as their cooperation in lung epithelial cells in these central neonatal diseases.
The pathogenesis of BPD is multifactorial, but the developmental arrest of alveolarization and inflammatory processes are key aberrations leading to this disease [2, 26, 27] . In the baboon model, equivalent to about 26 weeks of gestation in humans, the preterm animals develop alveolar hypoplasia and variable saccular wall fibrosis analogous to the pathology in lungs of human preterm infants [21] . We now show, both in preterm infants and in the baboon model that the development of chronic lung disease associates with increased expression of transcription factors GATA-6 and TTF-1 in the respiratory epithelium. Using a transgenic mouse model, others have previously demonstrated that increased GATA-6 expression in respiratory epithelial cells results in impaired pulmonary alveolarization and limited septation, thereby causing a histologic pattern resembling that of primate BPD [13] . In addition, the expression of GATA-6 was induced by TGF-␤ in human epithelial cell cultures.
Earlier work has revealed that TGF-␤ regulates and cooperates with GATA proteins in other tissues [28, 29] . It is noteworthy that in the pulmonary epithelial cell cultures, the effect of TGF-␤ was noted to regulate GATA-6 mRNA expression, whereas GATA-4, another GATA factor implicated in the lungs, was not stimulated. This implies that, of the GATA factors, GATA-6 participates in the regulation of abnormal processes in the neonatal lung. This hypothesis is further supported by recent findings showing that GATA-6 is crucial at all stages of pulmonary epithelial development and regeneration: it mediates epithelial stem cell development [30] , TGF-␤ -induced epithelial mesenchymal transition and the differentiation of fibroblasts to myofibroblasts [31] .
The transcriptional control of lung morphogenesis is complex. In the mouse, GATA-6 is required for the survival of progenitor cells for the bronchiolar epithelium, and it is essential for early differentiation and maturation of the lung [12, 30, 32] . We found that in the human lung, GATA-6 immunoreactivity in the airway epithelium was high during the second trimester, but diminished significantly towards term. This developmental pattern resembles the one in mice [13] and suggests a physiologic role for GATA-6 in human pulmonary development. Of note, the expression of TTF-1, a transcription factor related to GATA-6 in the regulation of lung-specific gene expression [14] , coincided with that of GATA-6 during development indicating their co-operation also in the human lung. GATA-6, together with TTF-1, is a known regulator of surfactant proteins A and C [14, 15] . It is possible that in the early phase of neonatal lung disease, the induction of GATA-6 and TTF-1 expression ensures surfactant synthesis in the type II pulmonary epithelial cells. In the RDS airway epithelium, increased GATA-6 and TTF-1 expression was first observed, but this subsequently decreased along with the prolongation of lung disease. The induction of these genes may be related to a protective induction in surfactant production by the alveolar epithelium, and later reflect epithelial injury often observed in late RDS.
Intrauterine as well as postnatal inflammatory processes are important in the pathogenesis of BPD [2] . However, the relationship between inflammation and developmental arrest is poorly understood [26, 33] . The TGF family of growth factors, e.g. TGF-␤ and bone morphogenetic proteins play a crucial role in the regulation of lung development and homeostasis [34] . Aberrant expression and activation of TGF-␤ are associated with abnormal lung development and pulmonary fibrosis both in the newborn and adult lung. Enhanced expression and activation of latent TGF-␤ contributes to pulmonary fibrosis progression [34, 35] , and high concentrations of TGF-␤ have been observed in the pulmonary fluid of preterm infants [36] . Enhanced TGF-␤ activation with consequent GATA-6 upregulation in the preterm lung may, in part, explain the development of BPD after inflammatory and hyperoxic injury to the lung. This hypothesis is further supported by the finding that TGF-␤ enhances GATA-6 expression in two different pulmonary epithelial cell lines. Transformed, adult cell lines were used due to the lack of suitable human embryonic or neonatal cell lines.
This is the first study to describe the temporal expression of GATA-6 in the developing normal and diseased lung. There are, however, obvious limitations to the conclusions that can be drawn from these data. It is practically impossible to find suitable control samples when assessing human RDS and BPD tissue samples. The sample size is rather small, as these are autopsied cases. It is therefore possible that differences in the fixation in premature versus term lungs compromise the finding on downregulated expression of GATA-6 and TTF-1 expression in the term lung, especially when this finding was not observed in the uniformly processed baboon lung.
All in all, earlier and current data reveal a temporal expression pattern for GATA-6 during fetal lung development in the mouse, baboon and human. In agreement with the earlier work in mice [13] , enhanced postnatal expression of GATA-6 and TTF-1 in pulmonary epithelium associates with the development of chronic lung disease in human preterm babies and baboons. Furthermore, TGF-␤ enhances the expression of GATA-6 and TTF-1 in human epithelial cell cultures. Signaling cascades involving TGF-␤ , GATA-6 and TTF-1 can be speculated to play an important role in the pathogenesis of BPD in preterm infants.
